| Primary |
| Attention Deficit/hyperactivity Disorder |
69.0% |
| Product Used For Unknown Indication |
19.0% |
| Asthma |
1.8% |
| Anxiety |
1.4% |
| Hypersensitivity |
1.3% |
| Insomnia |
1.1% |
| Autism |
1.1% |
| Depression |
1.0% |
| Disturbance In Attention |
0.6% |
| Seasonal Allergy |
0.6% |
| Convulsion |
0.5% |
| Affective Disorder |
0.4% |
| Bipolar Disorder |
0.4% |
| Sleep Disorder |
0.4% |
| Asperger's Disorder |
0.3% |
| Psychomotor Hyperactivity |
0.3% |
| Mood Swings |
0.2% |
| Hypothyroidism |
0.2% |
| Pain |
0.2% |
| Autism Spectrum Disorder |
0.2% |
|
| Product Quality Issue |
28.4% |
| No Adverse Event |
16.6% |
| Wrong Technique In Drug Usage Process |
10.9% |
| Off Label Use |
8.0% |
| Drug Administration Error |
6.4% |
| Drug Ineffective |
5.4% |
| Application Site Erythema |
4.6% |
| Incorrect Drug Administration Duration |
3.0% |
| Application Site Pruritus |
2.4% |
| Application Site Irritation |
1.9% |
| Drug Administered At Inappropriate Site |
1.9% |
| Drug Prescribing Error |
1.7% |
| Drug Dose Omission |
1.4% |
| Psychomotor Hyperactivity |
1.3% |
| Application Site Rash |
1.3% |
| Application Site Pain |
1.2% |
| Disturbance In Social Behaviour |
1.0% |
| Decreased Appetite |
0.9% |
| Abnormal Behaviour |
0.9% |
| Disturbance In Attention |
0.9% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
65.6% |
| Product Used For Unknown Indication |
14.6% |
| Anxiety |
2.8% |
| Autism |
2.5% |
| Disturbance In Attention |
1.6% |
| Hypersensitivity |
1.6% |
| Depression |
1.5% |
| Insomnia |
1.4% |
| Asthma |
1.3% |
| Convulsion |
1.2% |
| Asperger's Disorder |
0.8% |
| Affective Disorder |
0.7% |
| Oppositional Defiant Disorder |
0.7% |
| Impulsive Behaviour |
0.6% |
| Psychomotor Hyperactivity |
0.6% |
| Epilepsy |
0.5% |
| Mood Swings |
0.5% |
| Obsessive-compulsive Disorder |
0.5% |
| Crohn's Disease |
0.5% |
| Sleep Disorder |
0.5% |
|
| Product Quality Issue |
25.0% |
| Wrong Technique In Drug Usage Process |
18.9% |
| No Adverse Event |
10.0% |
| Drug Ineffective |
9.8% |
| Off Label Use |
7.2% |
| Drug Administration Error |
4.5% |
| Application Site Erythema |
3.3% |
| Drug Prescribing Error |
3.3% |
| Drug Administered At Inappropriate Site |
2.3% |
| Incorrect Drug Administration Duration |
2.3% |
| Decreased Appetite |
1.9% |
| Application Site Pruritus |
1.8% |
| Weight Decreased |
1.8% |
| Disturbance In Social Behaviour |
1.6% |
| Application Site Rash |
1.5% |
| Insomnia |
1.1% |
| Psychomotor Hyperactivity |
1.1% |
| Application Site Pain |
0.9% |
| Drug Dose Omission |
0.9% |
| Tic |
0.9% |
|
| Concomitant |
| Attention Deficit/hyperactivity Disorder |
33.1% |
| Product Used For Unknown Indication |
17.6% |
| Drug Use For Unknown Indication |
7.7% |
| Narcolepsy |
7.0% |
| Crohn's Disease |
4.9% |
| Affective Disorder |
3.5% |
| Asthma |
2.8% |
| Depression |
2.8% |
| Epilepsy |
2.8% |
| Anxiety |
2.1% |
| Bipolar Disorder |
2.1% |
| Enthesopathy |
2.1% |
| Constipation |
1.4% |
| Contraception |
1.4% |
| Growth Retardation |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Insomnia |
1.4% |
| Menorrhagia |
1.4% |
| Pain |
1.4% |
| Partial Seizures |
1.4% |
|
| Irritability |
10.3% |
| Tardive Dyskinesia |
10.3% |
| Rash |
7.7% |
| Vomiting |
7.7% |
| Aspartate Aminotransferase Increased |
5.1% |
| Device Breakage |
5.1% |
| Fatigue |
5.1% |
| Medication Error |
5.1% |
| Paranoia |
5.1% |
| Product Quality Issue |
5.1% |
| Retinal Aneurysm |
5.1% |
| Suicidal Ideation |
5.1% |
| Therapeutic Response Unexpected With Drug Substitution |
5.1% |
| Abdominal Pain Upper |
2.6% |
| Application Site Pruritus |
2.6% |
| Convulsion |
2.6% |
| Device Expulsion |
2.6% |
| Drug Ineffective |
2.6% |
| Dyspnoea |
2.6% |
| Dystonia |
2.6% |
|
